BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, December 5, 2025
Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 10, 1997

View Archived Issues

Merck & Co. describes avermectin analogue

Read More

Thrombin-binding anticoagulant disclosed by Japanese scientists

Read More

Fibrinogen receptor antagonists under development at E. Merck

Read More

New IL-4 antagonist from Hoechst

Read More

Roche describes antiproliferative agents

Read More

Merck Frosst discloses leukotriene biosynthesis inhibitors

Read More

Chondrex license agreement option exercised

Read More

Harvard Scientific to present impotence abstract

Read More

Sugen reports efficacy of novel antidiabetic drugs at H&Q conference

Read More

Pramlintide can be mixed with insulin

Read More

Cortecs launches Helisal One Step test in U.K.

Read More

Theratechnologies divests Pharmetics subsidiary

Read More

Four HY-TEC autoimmune test kits approved for U.S. marketing

Read More

Generic terfenadine approved for U.S. marketing

Read More

Antibody-based collaborative agreement reached by CaT and Lilly

Read More

Bristol-Myers Squibb/Cadus collaboration extended

Read More

Hyal receives notice of allowance for cardiovascular applications of hyaluronic acid

Read More

Clinical results with Natrecor in CHF patients reported in Circulation

Read More

Panretin phase I/II data described

Read More

Elan/Scherer Zydis formulation license agreement

Read More

Genetics Institute/Ontogeny functional genomics agreement

Read More

Phase I ConXn data reported

Read More

SIBIA Neurosciences/Aurora Biosciences drug discovery technology agreement

Read More

Antileukemic bisabolane sesquiterpene isolated from natural sources

Read More

Genzyme granted U.S. patent for mutation detection technology

Read More

Korean researchers report new immunosuppressant from natural source

Read More

Genzyme announces launch of instrument line

Read More

New manumycin-class antibiotics isolated at Tanabe Seiyaku

Read More

Kimmel Cancer Center's immunological disease therapy progress

Read More

New analgesic agent described by Japanese academics

Read More

Titan in-licenses antipsychotic drug from HMR

Read More

SciClone cystic fibrosis drug cleared for clinical testing

Read More

RPR seeks FDA approval for Nasacort-HFA

Read More

MedCare opens new U.S. treatment centers for urinary incontinence

Read More

Sequus' Amphotec earns 19th marketing approval

Read More

Access/Strakan license agreement

Read More

Labopharm granted US patent on drug delivery system

Read More

Further U.S. patent on Celtrix's SomatoKine

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 4, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 4, 2025.
  • Green molecules

    UK Biobank delivers largest metabolomics dataset of 500K profiles

    BioWorld Science
    It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
  • 3D rendering of prion structure

    Epigenetic technology could eliminate misfolded prion proteins

    BioWorld Science
    The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
  • Mesothelin is biomarker, potential target in arthritic bone damage

    BioWorld Science
    In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing